cGMP increases antioxidant function and attenuates oxidant cell death in mouse lung microvascular endothelial cells...

Area of Science:

• Cell Biology
• Biochemistry
• Pulmonary Medicine

Background:

• Endothelial cell damage from reactive oxygen species (ROS) is implicated in acute lung injury.
• The role of cyclic guanosine monophosphate (cGMP) in protecting pulmonary endothelial cells from cell death is not fully understood.

Purpose of the Study:

• To investigate the protective mechanisms of elevated intracellular cGMP against oxidative stress in mouse lung microvascular endothelial cells (MLMVECs).
• To determine the role of protein kinase G (PKG) in mediating cGMP's protective effects.

Main Methods:

• MLMVECs and isolated mouse lungs were challenged with hydrogen peroxide (H2O2) or subjected to ischemia-reperfusion.
• Intracellular cGMP levels were increased using 8pCPT-cGMP or atrial natriuretic peptide.
• Cell death, ROS levels, H2O2 scavenging, and protein/mRNA expression of antioxidant enzymes (catalase, glutathione peroxidase 1) were measured.
• Experiments were conducted in wild-type and PKG(I)-/- MLMVECs, with and without translation inhibition.

Main Results:

• Elevated cGMP significantly reduced H2O2-induced cell death in MLMVECs and decreased cell death in isolated lungs.
• cGMP increased endothelial H2O2 scavenging and decreased intracellular ROS.
• The protective effects were dependent on PKG(I) and involved increased protein levels of catalase and glutathione peroxidase 1, mediated by a posttranscriptional mechanism.
• These effects required prolonged cGMP incubation and were blocked by translation inhibition.

Conclusions:

• Intracellular cGMP, via PKG(I), confers protection against oxidative stress in pulmonary endothelial cells.
• This protection is achieved through increased expression of antioxidant enzymes catalase and glutathione peroxidase 1.
• The findings suggest a novel therapeutic strategy for acute lung injury by modulating cGMP signaling pathways.